Tesla, Nutanix, Meta and more
[ad_1] Check out the companies making headlines before the bell: Tesla (TSLA) – Tesla CEO Elon Musk said he would refrain from selling any more Tesla stock for 18 to…
A new Alzheimer’s treatment may help some patients, though researchers say more safety data is needed
[ad_1] A new study found that Eisai and Biogen’s experimental Alzheimer’s drug moderately reduced cognitive decline after a year and a half. Eisai’s 4523, +3.83% stock was up 1.7%% in…
Biogen, Thor Industries, Lyft and more
[ad_1] Check out the companies making headlines before the bell: Biogen (BIIB) – Biogen soared 45.6% in premarket trading after Biogen and Japanese partner Eisai said their experimental Alzheimer’s drug…